The Power of One

Samsung Biologics is driven to help create quality biomedicines that enrich life. We believe continued efforts to update current technology to the highest standards of safety and potency are essential to achieving this goal.

Our on-site Bio R&D Lab also offers up-to-date and technologically innovative sources of mRNA-LNP, enabling advanced manufacturing capability that is always ready for on-time customer satisfaction.

Cell-free mRNA drug substance production in a vial

Custom mRNA Services

With highest-level compliance and a dedicated team of mRNA experts, Samsung Biologics accommodates your needs by providing customized services for any scale-up study in mRNA and lipid nanoparticle (LNP) production.

  • Scope
    mRNA / saRNA / circRNA
  • IVT* Batch Capacity
    0.1 L to 200 L Single-use

*In vitro transcription

Agile mRNA Development Services

With our fully integrated solutions for mRNA GMP manufacturing that span process/method development, process/product characterization, and analytical testing, we help steer your innovative therapeutic through clinical and commercial stages.

Seamless CDMO Tech Transfer

Flexible scale-up precisely tailored to your needs

In the rapidly evolving mRNA industry where early-phase materials dominate, agile and swift small-scale production for clinical studies is essential. Samsung Biologics is ready for both current and future demands, offering seamless tech transfer with flexible scale-up from lab to commercial levels tailored to your needs.

One-stop mRNA Manufacturing Services

From pDNA linearization to fill & finish, Samsung Biologics uses flexible solutions and proven expertise to commit to an on-time, in-full delivery of mRNA vaccines and therapeutics we manufacture.

In-house Bioanalytical Services for GMP

Our customized quality control services for mRNA in vitro transcription (IVT), LNP, and fill-finish are conducted fully in-house, enabling swift release without undue delays.

  • IPC* Testing

    *In-process control

    • • Physical chemistry-based assays"
    • • Mass-based assays
    • • Plate reader-based assays
    • • Cell-based assays
  • Release Testing
    • • In-process control
    • • Compendial testing
    • • Microbial identification
    • • Sterility testing
    • • CCIT/Extractable volume
    • • Particulate testing
  • Biosafety Testing
    • • Bioburden testing
    • • Endotoxin detection and quantitation

*In-process control

Innovative Scientific Support

Proprietary sequence design features ranging from untranslated regions to unique poly(A) tail structures provide both contract research service and research collaboration opportunities. Tackling complex synthesis and purification processes can be customized for project-specific requirements.

  • mRNA sequence design
    • AI-based optimal sequence design algorithm platform with in-silico and in vitro validation
    • Customized mRNA sequence design service with improved protein expression profile and mRNA stability
  • Poly(A) tail shield
    • Proprietary mRNA tail sequence and structure with manufacturing advantages
    • Recombination-resistant design and QC-friendly homopolymeric characteristics
  • circular RNA (circRNA)
    • Manufacturing platform for novel forms of RNA structure
    • High circularization efficiency and purification of biologically active fractions

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION